Season 4 of Innovation Insider is focused on one core theme: innovating for the future of healthcare. Not incremental improvement. Not isolated pilots. Structural innovation that responds to ageing populations, chronic disease, cost pressure and accelerating technology.
To open the season, I sat down with Mark Hagland, one of the most experienced healthcare journalists covering healthcare innovation globally. Across nearly four decades, Mark has reported on the rise of managed care, the digitisation of medical records, value based payment reform and now artificial intelligence. His perspective cuts through hype and goes straight to the structural forces shaping health systems.
What follows are the key themes that matter most for leaders thinking about the future.
🎧 Listen on Spotify
🎬 Watch on YouTube
🎧 Listen on Apple
Scale does not automatically create efficiency
The United States spends roughly $4.6 trillion a year on healthcare. Over the past three decades, providers have consolidated into larger hospital systems and insurers have merged into a smaller group of dominant national players. On paper, this looks like rationalisation and maturity. In practice, as Mark pointed out, bigger has not necessarily meant better.
Hospitals bulked up to strengthen their negotiating power with insurers. Insurers consolidated to improve their leverage with providers. Yet the act of consolidation alone did not redesign care. True efficiency requires reworking how services are delivered, coordinated and measured. Without structural change beneath the surface, scale simply increases the size of the tension rather than resolving it.
For Australian leaders, this is an important reminder. Growth and mergers may shift market dynamics, but they do not guarantee better outcomes or lower costs. Innovation requires redesign, not just aggregation.
“I refer to our healthcare industry as the $4.6 trillion annual mom and pop shop.”
The real shift from disease management to whole person care
One of the most important innovations Mark described was the evolution from siloed disease programs to integrated care management. The archetypal “Mrs Smith” has multiple chronic conditions such as heart failure, diabetes and chronic lung disease. Historically, each condition would have been managed separately, often by different teams with limited coordination.
The emerging model treats Mrs Smith as a whole person. Remote monitoring devices track weight, blood pressure and glucose levels. Nurse case managers proactively review trends. Data analytics identify early warning signals before deterioration leads to hospitalisation. Payment models increasingly reward keeping patients stable rather than simply reimbursing episodes of care.
This shift is critical in a world defined by ageing populations and chronic disease. The innovation is not flashy. It is systemic. It requires alignment across payers, providers and hospitals, and it demands sustained engagement rather than one off interventions.
“We’ve got this explosion in chronic disease. The only way to get a handle on it is for everyone to collaborate together.”
Incentives shape behaviour more than technology
In the US, most working age adults receive health insurance through their employer. Employers regularly switch insurers in search of better premiums, creating a high level of churn. Insurers operate on thin margins and face intense pricing pressure. Patients are frequently moved from one health plan to another.
This structural reality creates discontinuity. If you are Mrs Smith and your insurer changes each year, your incentive to deeply engage in long term preventative programs weakens. If you are an insurer and you may lose that member next year, your willingness to invest in multi year care management initiatives diminishes. Innovation struggles when incentives are short term.
“If you knew you were going to be covered for ten years, you would invest more of your energy as a healthcare consumer.”
The lesson is broader than the US context. Healthcare innovation succeeds when financial incentives, clinical goals and patient engagement move in the same direction. When those incentives are misaligned, even strong technology and good intentions fail to scale.
Download a free copy of our PHI Innovation Report
It’s Australia’s definitive benchmark of private health insurance innovation, ranking the nation’s leading funds and revealing the strategies reshaping affordability, prevention and digital care.
Exclusively free for Innovation Insiders
Digital infrastructure made modern innovation possible
Mark was unequivocal about the transformative impact of electronic health records. Before digitisation, hospitals were buried in paper files, and meaningful population analysis was painfully slow. Following legislative reform in 2009, digital adoption accelerated across US hospitals and physician groups, fundamentally changing what was possible.
Once data became accessible and searchable, health systems could track readmissions, identify high risk cohorts and support alternative payment models with real time insights. The electronic record did not solve every problem, but it created the foundation upon which analytics and AI could be built.
“When you look at what was possible in 2008 and what’s possible in 2026, it’s a completely different world.”
For leaders thinking about the future, this reinforces a simple truth: technology is cumulative. Each layer enables the next. Without strong digital foundations, more advanced innovation stalls.
AI as augmentation, not replacement
Artificial intelligence is the current headline innovation, yet the most interesting developments are practical rather than futuristic. Radiologists are using AI to prioritise urgent scans so life threatening findings are reviewed first. Oncologists are relying on algorithms to navigate overwhelming clinical trial data. Dermatologists are triaging patients more effectively in the face of workforce shortages.
The early fear that machines would replace clinicians is giving way to a more grounded understanding. AI is becoming an augmentation tool. It reduces documentation burden, surfaces relevant information and supports faster decision making. Crucially, many health systems are pairing deployment with governance structures to ensure safe and responsible implementation.
“Physicians were very afraid of AI a few years ago… Now they’re realising AI is not going to replace them. It’s going to be the tool that helps them function better.”
In three years, this conversation will likely look different again. The trajectory is clear. The question is how quickly systems can adapt.
Hospital at home challenges traditional models
Another structural shift gaining momentum is hospital at home. Instead of treating all moderate acuity patients inside hospital walls, health systems are increasingly delivering acute level care in patients’ homes, supported by remote monitoring and virtual command centres.
This model is disruptive because it forces hospitals to rethink bed capacity, workforce deployment and revenue assumptions. An 800 bed hospital contemplating a future with fewer beds is not a small adjustment. Yet both in the US and Australia, major providers are leaning into this shift as cost pressures and workforce shortages intensify.
Hospital at home is not simply a service innovation. It is a redefinition of what a hospital actually is.
“We need to get more people out of the inpatient hospital if we’re going to save money.”
There is no universal blueprint
When asked which country has the most innovative healthcare system, Mark’s response was nuanced. Smaller, affluent countries with cohesive governance structures can often move faster. Nordic nations are frequently cited. Australia and Canada have structural advantages compared to much larger systems.
The US, by contrast, is vast and deeply unequal. In affluent suburbs of major cities, care can be exceptional. In under resourced rural or inner city areas, the challenges are stark. Healthcare systems reflect the broader economic, cultural and demographic contexts in which they operate. There is no model that can simply be lifted and transplanted.
For those focused on innovating for the future of healthcare, this is perhaps the most important insight of all. Innovation must be contextual. It must respond to the incentives, constraints and characteristics of the system in which it operates.
Season 4 will continue to explore these structural tensions, not just the technologies layered on top of them. If we are serious about the future of healthcare, we must look beyond surface level change and focus on redesigning incentives, models of care and governance structures.
🎧 Catch to the full episode with Mark Hagland on Innovation Insider as we unpack what global experience can teach us about innovating for the future of healthcare.
🎧 Listen on Spotify
🎬 Watch on YouTube
🎧 Listen on Apple
Subscribe to Innovation Insider so you never miss an episode 👇🏻